The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionFull Access

Correction

Published Online:

In the February review article “Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials” by Geddes et al. (Am J Psychiatry 2004; 161:217–222), there was an error in Table 1: the previous lithium use in the Kane et al. 1982 study should have been listed as “Unclear.” Also, in Figure 3, the rate of depressive relapse with placebo in the Bowden et al. 2003 study should have been 30% (N=21 of 70). The pooled depressive relapse rate with placebo was therefore 30% (N=89 of 297) rather than 32%. The pooled fixed effect relative risk (reported on p. 219) was 0.83 (95% CI=0.63–1.08), and the random effects relative risk was 0.85 (95% CI=0.66–1.11). These changes do not materially change the conclusions of the article.